کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
1220572 1494615 2016 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Design of experiments for enantiomeric separation in supercritical fluid chromatography
ترجمه فارسی عنوان
طراحی آزمایش برای جداسازی آنتی آمینور در کروماتوگرافی سیال فوق کریتیک
کلمات کلیدی
جدایی کریال، طراحی تجربی، لیگاندهای ملاتونینژیک، نفتالن، بهینه سازی، فاز ثابت کیهانی پلی ساکارید
موضوعات مرتبط
مهندسی و علوم پایه شیمی شیمی آنالیزی یا شیمی تجزیه
چکیده انگلیسی


• Combined effect of ethanol percentage, pressure and flow-rate is studied in SFC.
• Design of experiments is implemented to determine optimal conditions.
• Ethanol fraction was most important for retention, and resolution.
• Optimized conditions were used to carry out preparative scale.

A new chiral melatoninergic ligand, potentially successor of Valdoxan®, presenting an improved pharmacological profile with regard to agomelatine, was chosen as a probe for a supercritical fluid chromatographic separation carried-out on an amylose tris[(S)-1-α-methylbenzylcarbamate] based stationary phase.The goal of this work was to optimize simultaneously three factors identified to have a significant influence to obtain the best resolution in the shortest analysis time (i.e., retention time of the second eluting enantiomer) for this chiral compound.For this purpose a central circumscribed composite (CCC) design was developed with three factors: the flow-rate, the pressure outlet and the percentage of ethanol to optimize of two responses: shortest analysis time and best resolution. The optimal conditions obtained via the optimizer mode of the software (using the Nelder-Mead method) i.e., CO2/EtOH 86:14 (v:v), 104 bar, 3.2 mL min−1 at 35 °C lead to a resolution of 3.27 in less than 6 min. These conditions were transposed to a preparative scale where a concentrated methanolic solution of 40 mM was injected with a sample loop of 100 μL. This step allowed to separate an amount of around 65 mg of racemic melatonin ligand in only 3 h with impressive yields (97%) and enantiomeric excess (99.5%).

Figure optionsDownload as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Pharmaceutical and Biomedical Analysis - Volume 120, 20 February 2016, Pages 297–305
نویسندگان
, , , ,